The roots of DFE Pharma date back to more than 100 years ago, when two dairy producers, in both the Netherlands and New Zealand, gradually transformed into modern producers of lactose excipients and joined to become the world’s leading excipient manufacturer. The abbreviation of these two companies DMV-Fonterra Excipients, led to the first part of our name, “DFE”, which is complemented by “Pharma”, as we are an independent company focused on the (bio)pharmaceutical and nutraceutical industry, by providing a broad premium quality portfolio of excipients for use in Biopharma, Inhalation, Oral Solid Dose and Nutraceuticals products.

Since 2020, DFE Pharma is jointly owned by Royal FrieslandCampina, one of the world’s top multi-national dairy companies, and CVC Capital Partners, a leading global investor, holding a 50% share each of them. The combination of these two shareholders supports DFE Pharma's growth ambitions and provides further opportunities to excel as a global leader in pharmaceutical ingredients.